Biden promises to speed up coronavirus vaccine production

President-elect Joe Biden on Tuesday criticized the Trump administration's plan for distributing coronavirus vaccines, saying if doses are administered at their current rate, "it will take years, not months, to vaccinate the American people."
Federal officials had vowed that 20 million people would be vaccinated by the end of this year, but the Centers for Disease Control and Prevention says only about 2.1 million Americans have so far received their initial vaccine dose. "As I long feared and warned, the effort to distribute and administer the vaccine is not progressing as it should," Biden said.
The vaccine shows that "brighter days are coming," Biden stated, but with coronavirus cases surging and more than 334,000 Americans dead, this isn't a jubilant time. "We need to be honest: The next few weeks and months are going to be very tough, a very tough period for our nation — maybe the toughest during this entire pandemic," Biden said. "I know it's hard to hear, but it's the truth."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Biden promised that once he is in office, he will invoke the Defense Production Act so companies can ramp up production of personal protective equipment and vaccine-related materials. In his first 100 days, he will push to distribute 100 million vaccine doses and work to reopen most K-8 schools, but Biden said for this to happen, Congress needs to approve additional funding for increased testing, cleaning, and new ventilation systems.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Trump pauses Ukraine intelligence sharing
Speed Read The decision is intended to pressure Ukrainian President Volodymyr Zelenskyy into peace negotiations with Vladimir Putin
By Peter Weber, The Week US Published
-
Supreme Court rules against Trump on aid freeze
Speed Read The court rejected the president's request to freeze nearly $2 billion in payments for foreign humanitarian work
By Rafi Schwartz, The Week US Published
-
'If you keep people permanently unhappy, you cannot have a stable society'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published